Biotechnology Company Initiates Patient Enrollment For Oral Lichen Planus Trial
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients.
Disclaimer: The following article provides information on Lipella Pharmaceuticals' latest clinical trial. It is intended for informational purposes only and does not constitute medical advice. Always consult healthcare professionals for medical conditions and treatments.
Real-time information is available daily at https://stockreg…